Plain-English translation of NCT06690112 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After surgery to remove a stomach cancer tumor, some patients have significant fluid drainage from the surgical site. This trial is testing whether it's safer to send patients home with the drainage tube still in place or to remove it before discharge. The study will follow 60 patients for four weeks after surgery to see if one approach leads to fewer infections or other complications.
Doctors aren't sure whether keeping a drainage tube in place after going home helps prevent dangerous complications like infection or fluid buildup, or whether removing it is just as safe. This study will provide clear evidence to guide the best practice for future patients.
You likely qualify if…
You likely don't qualify if…
After your stomach cancer surgery, if you meet the study requirements on day 4, you'll be randomly assigned to either keep your drainage tube when you go home or have it removed before discharge. You'll receive standard postoperative care and be followed up with clinic visits at 1 and 3 weeks after you leave the hospital, plus imaging scans if needed. The study team will monitor you for four weeks total to check for any complications like infection or fluid buildup.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
South Korea